Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 3050265)

Published in Klin Wochenschr on August 01, 1988

Authors

P Gross1, M Ketteler, C Hausmann, C Reinhard, A Schömig, E Hackenthal, E Ritz, W Rascher

Author Affiliations

1: Medizinische Universitätsklinik, Pharmakologisches Institut, Heidelberg.

Articles citing this

Clinical management of SIADH. Ther Adv Endocrinol Metab (2012) 1.13

Cicletanine-induced hyponatremia and hypokalemia in kidney transplant patients. Kidney Res Clin Pract (2016) 0.75

Articles by these authors

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24

Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k. EMBO J (1997) 5.57

Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev (2000) 5.53

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med (1996) 5.46

The Heidelberg classification of renal cell tumours. J Pathol (1997) 5.36

Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science (1997) 4.19

Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc Natl Acad Sci U S A (1994) 4.16

Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol Cell Biol (1996) 3.82

Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet (1999) 3.38

Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr (1997) 3.29

The nephrotic syndrome. N Engl J Med (1998) 3.22

Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet (1998) 2.98

Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors. Proc Natl Acad Sci U S A (2001) 2.77

PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. Nat Cell Biol (2001) 2.69

Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis (2001) 2.42

Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int (2007) 2.42

Hantavirus infection presenting as acute renal failure. Lancet (1990) 2.40

Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant (2000) 2.38

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation (2001) 2.34

Cell autonomous regulation of multiple Dishevelled-dependent pathways by mammalian Nkd. Proc Natl Acad Sci U S A (2001) 2.22

Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation (1996) 2.20

Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. Eur Heart J (2001) 2.06

Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial. Circulation (1997) 2.06

The rising tide of endstage renal failure from diabetic nephropathy type II--an epidemiological analysis. Nephrol Dial Transplant (1995) 2.06

Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J Biol Chem (1998) 2.01

Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab (1997) 1.99

Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest (1989) 1.98

Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation (1998) 1.95

Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol (1997) 1.84

Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int (2007) 1.83

Women encounter ADRs more often than do men. Eur J Clin Pharmacol (2008) 1.83

Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest (1995) 1.79

Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int (1998) 1.77

Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation (1996) 1.75

Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure. Lancet (1985) 1.74

Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol (1998) 1.73

Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant (1998) 1.71

Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation (1995) 1.66

Hyponatraemia as a complication of colonoscopy. Lancet (2001) 1.66

Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1,147 unselected patients. Catheter Cardiovasc Interv (2000) 1.65

Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation (1998) 1.63

Sticky platelet syndrome: an underrecognized cause of graft dysfunction and thromboembolic complications in renal transplant recipients. Am J Transplant (2007) 1.63

Vessel size and long-term outcome after coronary stent placement. Circulation (1998) 1.61

Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FK506-binding protein 12 upregulation. Circulation (2001) 1.61

Disturbed calcium metabolism in subjects with elevated diastolic blood pressure. Clin Investig (1992) 1.61

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int (1998) 1.61

Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation. J Intern Med (2008) 1.60

Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. Thromb Haemost (1984) 1.59

Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation (2000) 1.56

PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement. J Am Coll Cardiol (2000) 1.56

Operator volume and outcome of patients undergoing coronary stent placement. J Am Coll Cardiol (1998) 1.56

Dissociation between coronary sinus and left atrial conduction in patients with atrial fibrillation and flutter. J Cardiovasc Electrophysiol (2001) 1.56

Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. J Am Coll Cardiol (2001) 1.55

Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension. Nephrol Dial Transplant (1995) 1.54

A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion. Eur Heart J (1997) 1.53

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial. Lancet (2001) 1.53

Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy. J Thromb Haemost (2010) 1.52

Hypoxia activates the human placental vascular endothelial growth factor system in vitro and in vivo: up-regulation of vascular endothelial growth factor in clinically relevant hypoxic ischemia in birth asphyxia. Am J Obstet Gynecol (2003) 1.51

Persistent improvement of gas exchange and lung mechanics by aerosolized perfluorocarbon. Am J Respir Crit Care Med (2001) 1.51

Validity and reliability of 24h blood pressure monitoring in children and adolescents using a portable, oscillometric device. J Hum Hypertens (1994) 1.51

Comparison of angiography and intravascular ultrasound for the assessment of lumen size after coronary stent placement: impact of dilation pressures. Cathet Cardiovasc Diagn (1997) 1.49

Isotretinoin alleviates renal damage in rat chronic glomerulonephritis. Kidney Int (2001) 1.49

Toxicity, clearance and distribution of endotoxin in mice as influenced by actinomycin D, cycloheximide, -amanitin and lead acetate. Toxicon (1972) 1.49

In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int (1993) 1.49

Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis. Proc Natl Acad Sci U S A (1997) 1.48

Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes (1997) 1.48

Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. Clin Nephrol (1997) 1.48

Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation (1997) 1.47

Brief adrenomedullin inhalation leads to sustained reduction of pulmonary artery pressure. Eur Respir J (2004) 1.47

Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors In vivo by ultrasound-guided injection or transcoronary delivery. Circulation (2000) 1.45

Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosis. Thromb Haemost (2012) 1.45

A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries. J Intern Med (2004) 1.43

[Is there a correlation between C-reactive protein and calcification inhibitors with cardiovascular parameters and risk factors in hemodialysis patients?]. Dtsch Med Wochenschr (2007) 1.43

Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 study. Nephrol Dial Transplant (2000) 1.43

Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel. J Thromb Haemost (2006) 1.43

Genesis and significance of hypertension in autosomal dominant polycystic kidney disease. Nephron (1994) 1.42

Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group. Perit Dial Int (1996) 1.42

Gene transfer of heterologous G protein-coupled receptors to cardiomyocytes: differential effects on contractility. Circ Res (2001) 1.42

The response of GFR to amino acids differs between autosomal dominant polycystic kidney disease (ADPKD) and glomerular disease. Nephrol Dial Transplant (1992) 1.41

Parathyroidectomy in secondary (renal) hyperparathyroidism--whom, when, how? Int J Artif Organs (1993) 1.41

Recovery from withdrawal of inhaled nitric oxide and kinetics of nitric oxide-induced inhibition of nitric oxide synthase activity in vitro. Intensive Care Med (2000) 1.40

The value of renal scintigraphy during controlled diuresis in children with hydronephrosis. Eur J Nucl Med (1999) 1.40

[Type II diabetes. Pathophysiology of insulin resistance, rules and goals of therapy]. Dtsch Med Wochenschr (1995) 1.40

Horseshoe kidney. Nephrol Dial Transplant (1999) 1.40

G protein beta3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placement. Atherosclerosis (2000) 1.39

Primary obstructed megaureter in neonates. Treatment by temporary uretero-cutaneostomy. Br J Urol (1993) 1.39

[Therapy of hyperammonemia in carbamyl phosphate synthase deficiency with peritoneal dialysis and venovenous hemofiltration]. Monatsschr Kinderheilkd (1991) 1.39

[Routine screening for microalbuminemia in type 2 diabetes mellitus--pro]. Dtsch Med Wochenschr (2003) 1.39

[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]. Dtsch Med Wochenschr (2004) 1.39

Night time blood pressure in diabetic patients--the submerged portion of the iceberg? Nephrol Dial Transplant (1999) 1.39

Rapidly progressive glomerulonephritis in a patient with Henoch-Schoenlein purpura. Spontaneous recovery of renal function after six months of maintenance hemodialysis. Clin Nephrol (1995) 1.39

Is control of secondary hyperparathyroidism optimal with the currently used calcium concentration in the CAPD fluid? Nephrol Dial Transplant (1991) 1.38

Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38

Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Cardiol (1996) 1.38

Early recovery of coronary flow reserve after stent implantation as assessed by positron emission tomography. J Am Coll Cardiol (1999) 1.38

Analgesic nephropathy. Nephrol Dial Transplant (1996) 1.38

Natriuretic factors and lithium clearance in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) Eur J Clin Invest (1989) 1.38